Intravenous iloprost may be an effective first-line treatment for persistent pulmonary hypertension of the newborn in limited-resource situations

1. Walsh-Sukys MC, Tyson JE, Wright LL, Bauer CR, Korones SB, Stevenson DK, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000; 105:14-20.10.1542/peds.105.1.1410617698Open DOISearch in Google Scholar

2. Nakwan N, Nakwan N, Wannaro J. Predicting mortality outcome in infants with persistent pulmonary hypertension of the newborn with the Score for Neonatal Acute Physiology-Version II (SNAP-II) in Thai neonates. J Perinat Med. 2011; 39:311-5.10.1515/jpm.2011.01121488808Search in Google Scholar

3. Vargas-Origel A, Gomez-Rodríguez G, Aldana- Valenzuela C, Vela-Huerta MM, Alarcon-Santos SB, Amador-Licona N. The use of sildenafil in persistent pulmonary hypertension of the newborn. Am J Perinatol. 2010; 27:225-30.10.1055/s-0029-123949619866403Open DOISearch in Google Scholar

4. Nakwan N, Nakwan N, Choksuchat D, Saksawad R, Thammachote P. Successful treatment of persistent pulmonary hypertension of the newborn with bosentan. Acta Paediatr. 2009; 98:1683-5.10.1111/j.1651-2227.2009.01386.x19523174Open DOISearch in Google Scholar

5. Nakwan N, Nakwan N, Wanaro J. Persistent pulmonary hypertension of the newborn successfully treated with beraprost sodium: a retrospective chart review. Neonatology. 2011; 99:33-7.10.1159/00029813720588068Search in Google Scholar

6. Mohamed WA, Ismail M. A randomized, double-blind, placebo-controlled, prospective study of bosentan for the treatment of persistent pulmonary hypertension of the newborn. J Perinatol. 2012; 32:608-13.10.1038/jp.2011.15722076415Open DOISearch in Google Scholar

7. Ewert R, Opitz CF, Wensel R, Winkler J, Halank M, Felix SB. Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Clin Res Cardiol. 2007; 96:211-7.10.1007/s00392-007-0490-317294349Open DOISearch in Google Scholar

8. Hoeper MM, Schwarze M, Ehlerding S, Adler- Schuermeyer A, Spiekerkoetter E, Niedermeyer J, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med. 2000; 342:1866-70.10.1056/NEJM20000622342250310861321Search in Google Scholar

9. Limsuwan A, Khosithseth A, Wanichkul S, Khowsathit P. Aerosolized iloprost for pulmonary vasoreactivity testing in children with long-standing pulmonary hypertension related to congenital heart disease. Catheter Cardiovasc Interv. 2009; 73:98-104.10.1002/ccd.2179319089967Search in Google Scholar

10. Chotigeat U, Jaratwashirakul S. Inhaled iloprost for severe persistent pulmonary hypertension of the newborn. J Med Assoc Thai. 2007; 90:167-70.Search in Google Scholar

11. De Luca D, Zecca E, Piastra M, Romagnoli C. Iloprost as ‘rescue’ therapy for pulmonary hypertension of the neonate. Paediatr Anaesth. 2007; 17:394-5.10.1111/j.1460-9592.2006.02104.x17359413Open DOISearch in Google Scholar

12. Ehlen M, Wiebe B. Iloprost in persistent pulmonary hypertension of the newborn. Cardiol Young. 2003; 13:361-3 .10.1017/S1047951103000726Open DOISearch in Google Scholar

13. Greenough A, Khetriwal B. Pulmonary hypertension in the newborn: Paediatr Respir Rev. 2005; 6:111-6.10.1016/j.prrv.2005.03.005Open DOISearch in Google Scholar

14. Schror K, Darius H, Matzky R, Ohlendorf R. The anti-platelet and cardiovascular actions of a new carbacyclin derivative (ZK36374) - equipotent to PGI2 in vitro. Arch Pharmacol. 1981; 316:252-5.10.1007/BF00505658Search in Google Scholar

15. Bugiardini R, Galvani M, Ferrini D, Gridelli C, Mari L, Puddu P, et al. Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris. Am J Cardiol. 1986; 58:453-9.10.1016/0002-9149(86)90014-7Open DOISearch in Google Scholar

16. Kaukinen S, Ylitalo P, Pessi T, Vapaatalo H. Hemodynamic effects of iloprost, a prostacyclin analog. Clin Pharmacol Ther. 1984; 36:464-9.10.1038/clpt.1984.2056206978Open DOISearch in Google Scholar

17. Hoeper MM, Spiekerkoetter E, Westerkamp V, Gatzke R, Fabel H. Intravenous iloprost for treatment failure of aerosolised iloprost in pulmonary arterial hypertension. Eur Respir J. 2002; 20:339-43.10.1183/09031936.02.0246200112212965Open DOISearch in Google Scholar

18. Higenbottam TW, Butt AY, Dinh-Xaun AT, Takao M, Cremona G, Akamine S. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart. 1998: 79;175-9.10.1136/hrt.79.2.17517285979538312Open DOISearch in Google Scholar